Chemoinformaics analysis of 5,7-DIHYDROXY-2-(4-HYDROXYPHENYL)-6,8-DIMETHOXYCHROMEN-4-ONE
| Molecular Weight | 330.292 | nRot | 3 |
| Heavy Atom Molecular Weight | 316.18 | nRig | 18 |
| Exact Molecular Weight | 330.074 | nRing | 3 |
| Solubility: LogS | -3.792 | nHRing | 1 |
| Solubility: LogP | 2.925 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 17 |
| nHA | 7 | APOL | 43.3391 |
| nHD | 3 | BPOL | 20.1209 |
| QED | 0.677 |
| Synth | 2.532 |
| Natural Product Likeliness | 1.425 |
| NR-PPAR-gamma | 0.952 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.962 |
| Pgp-sub | 0.002 |
| HIA | 0.046 |
| CACO-2 | -4.896 |
| MDCK | 0.0000145 |
| BBB | 0.004 |
| PPB | 0.929427 |
| VDSS | 0.688 |
| FU | 0.136589 |
| CYP1A2-inh | 0.897 |
| CYP1A2-sub | 0.934 |
| CYP2c19-inh | 0.22 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.775 |
| CYP2c9-sub | 0.854 |
| CYP2d6-inh | 0.393 |
| CYP2d6-sub | 0.305 |
| CYP3a4-inh | 0.348 |
| CYP3a4-sub | 0.166 |
| CL | 2.92 |
| T12 | 0.864 |
| hERG | 0.141 |
| Ames | 0.495 |
| ROA | 0.212 |
| SkinSen | 0.701 |
| Carcinogencity | 0.25 |
| EI | 0.729 |
| Respiratory | 0.095 |
| NR-Aromatase | 0.907 |
| Antiviral | Yes |
| Prediction | 0.769765 |